XML 134 R120.htm IDEA: XBRL DOCUMENT
v3.22.4

Segment Disclosures - Summary Information for the Reportable Segments (Details) - USD ($) $ in Thousands | 1 Months Ended | 3 Months Ended | 12 Months Ended
--- | --- | --- | ---
Jul. 31, 2022 | Jan. 31, 2022 | Dec. 31, 2022 | Sep. 30, 2022 | Jun. 30, 2022 | Mar. 31, 2022 | Dec. 31, 2021 | Sep. 30, 2021 | Jun. 30, 2021 | Mar. 31, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020
Segment Reporting Information, Revenue for Reportable Segment [Abstract] |  |  |  |  |  |  |  |  |  |  |  |  |
Total revenues |  |  | $ 524,468 | $ 520,406 | $ 517,932 | $ 498,372 | $ 483,205 | $ 481,465 | $ 476,238 | $ 455,276 | $ 2,061,178 | $ 1,896,184 | $ 1,644,875
Government grant income |  |  |  |  |  |  |  |  |  |  | 6,765 | 1,412 | 16,198
Less: Interest income |  |  |  |  |  |  |  |  |  |  | (23,300) | (37,773) | (16,553)
Healthpeak’s share of unconsolidated joint venture total revenues |  |  |  |  |  |  |  |  |  |  | 86,805 | 83,377 | 112,635
Healthpeak’s share of unconsolidated joint venture government grant income |  |  |  |  |  |  |  |  |  |  | 878 | 1,749 | 1,279
Noncontrolling interests’ share of consolidated joint venture total revenues |  |  |  |  |  |  |  |  |  |  | (35,985) | (35,655) | (34,836)
Operating expenses |  |  |  |  |  |  |  |  |  |  | (862,991) | (773,279) | (782,541)
Healthpeak’s share of unconsolidated joint venture operating expenses |  |  |  |  |  |  |  |  |  |  | (61,693) | (61,515) | (87,170)
Noncontrolling interests’ share of consolidated joint venture operating expenses |  |  |  |  |  |  |  |  |  |  | 10,404 | 10,158 | 10,354
Adjustments to NOI |  |  |  |  |  |  |  |  |  |  | (75,798) | (54,513) | 71,828
Adjusted NOI |  |  |  |  |  |  |  |  |  |  | 1,106,263 | 1,030,145 | 936,069
Plus: Adjustments to NOI |  |  |  |  |  |  |  |  |  |  | 75,798 | 54,513 | (71,828)
Interest income |  |  |  |  |  |  |  |  |  |  | 23,300 | 37,773 | 16,553
Interest expense |  |  |  |  |  |  |  |  |  |  | (172,944) | (157,980) | (218,336)
Depreciation and amortization |  |  |  |  |  |  |  |  |  |  | (710,569) | (684,286) | (553,949)
General and administrative |  |  |  |  |  |  |  |  |  |  | (131,033) | (98,303) | (93,237)
Transaction costs |  |  |  |  |  |  |  |  |  |  | (4,853) | (1,841) | (18,342)
Impairments and loan loss reserves, net |  |  |  |  |  |  |  |  |  |  | (7,004) | (23,160) | (42,909)
Gain (loss) on sales of real estate, net |  |  |  |  |  |  |  |  |  |  | 9,078 | 190,590 | 90,350
Gain (loss) on debt extinguishments |  |  |  |  |  |  |  |  |  |  | 0 | (225,824) | (42,912)
Other income (expense), net |  |  |  |  |  |  |  |  |  |  | 326,268 | 6,266 | 234,684
Less: Government grant income |  |  |  |  |  |  |  |  |  |  | (6,765) | (1,412) | (16,198)
Less: Healthpeak’s share of unconsolidated joint venture NOI |  |  |  |  |  |  |  |  |  |  | (25,990) | (23,611) | (26,744)
Plus: Noncontrolling interests’ share of consolidated joint venture NOI |  |  |  |  |  |  |  |  |  |  | 25,581 | 25,497 | 24,482
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures |  |  |  |  |  |  |  |  |  |  | 507,130 | 128,367 | 217,683
Income tax benefit (expense) |  |  |  |  |  |  |  |  |  |  | 4,425 | 3,261 | 9,423
Equity income (loss) from unconsolidated joint ventures |  |  |  |  |  |  |  |  |  |  | 1,985 | 6,100 | (66,599)
Income (loss) from continuing operations |  |  | 9,929 | 359,284 | 69,301 | 75,026 | 28,943 | 61,305 | 168,065 | (120,585) | 513,540 | 137,728 | 160,507
Income (loss) from discontinued operations |  |  | 873 | (1,298) | 2,992 | 317 | 3,633 | 601 | 113,960 | 270,008 | 2,884 | 388,202 | 267,746
Net income (loss) |  |  | $ 10,802 | $ 357,986 | 72,293 | $ 75,343 | $ 32,576 | $ 61,906 | $ 282,025 | $ 149,423 | 516,424 | 525,930 | 428,253
Tax benefit recognized in conjunction with internal restructuring activities |  |  |  |  |  |  |  |  |  |  |  |  | 51,000
Valuation allowance on deferred assets no longer realized |  |  |  |  |  |  |  |  |  |  |  |  | 33,000
Tax benefit recognized from CARES Act |  |  |  |  |  |  |  |  |  |  |  |  | 3,700
Corporate Non-segment |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information, Revenue for Reportable Segment [Abstract] |  |  |  |  |  |  |  |  |  |  |  |  |
Total revenues |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
Government grant income |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
Less: Interest income |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
Healthpeak’s share of unconsolidated joint venture total revenues |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
Healthpeak’s share of unconsolidated joint venture government grant income |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
Noncontrolling interests’ share of consolidated joint venture total revenues |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
Operating expenses |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
Healthpeak’s share of unconsolidated joint venture operating expenses |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
Noncontrolling interests’ share of consolidated joint venture operating expenses |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
Adjustments to NOI |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
Adjusted NOI |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
Plus: Adjustments to NOI |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
Interest income |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
Interest expense |  |  |  |  |  |  |  |  |  |  | (158,535) | (147,210) | (210,475)
Depreciation and amortization |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
General and administrative |  |  |  |  |  |  |  |  |  |  | (131,033) | (98,303) | (93,237)
Transaction costs |  |  |  |  |  |  |  |  |  |  | (2,486) | 0 | 0
Impairments and loan loss reserves, net |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
Gain (loss) on sales of real estate, net |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
Gain (loss) on debt extinguishments |  |  |  |  |  |  |  |  |  |  |  | (225,824) | (42,912)
Other income (expense), net |  |  |  |  |  |  |  |  |  |  | 3,013 | 6,309 | 5,133
Less: Government grant income |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
Less: Healthpeak’s share of unconsolidated joint venture NOI |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
Plus: Noncontrolling interests’ share of consolidated joint venture NOI |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures |  |  |  |  |  |  |  |  |  |  | (289,041) | (465,028) | (341,491)
Income tax benefit (expense) |  |  |  |  |  |  |  |  |  |  | 4,425 | 3,261 | 9,423
Equity income (loss) from unconsolidated joint ventures |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
Income (loss) from continuing operations |  |  |  |  |  |  |  |  |  |  | (284,616) | (461,767) | (332,068)
Income (loss) from discontinued operations |  |  |  |  |  |  |  |  |  |  | 2,884 | 388,202 | 267,746
Net income (loss) |  |  |  |  |  |  |  |  |  |  | (281,732) | (73,565) | (64,322)
Life Science |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information, Revenue for Reportable Segment [Abstract] |  |  |  |  |  |  |  |  |  |  |  |  |
Gain (loss) on sales of real estate, net |  | $ 4,000 |  |  |  |  |  |  |  |  |  |  |
Life Science | Operating Segment |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information, Revenue for Reportable Segment [Abstract] |  |  |  |  |  |  |  |  |  |  |  |  |
Total revenues |  |  |  |  |  |  |  |  |  |  | 817,573 | 715,844 | 569,296
Government grant income |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
Less: Interest income |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
Healthpeak’s share of unconsolidated joint venture total revenues |  |  |  |  |  |  |  |  |  |  | 9,921 | 5,757 | 448
Healthpeak’s share of unconsolidated joint venture government grant income |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
Noncontrolling interests’ share of consolidated joint venture total revenues |  |  |  |  |  |  |  |  |  |  | (268) | (292) | (239)
Operating expenses |  |  |  |  |  |  |  |  |  |  | (209,143) | (169,044) | (138,005)
Healthpeak’s share of unconsolidated joint venture operating expenses |  |  |  |  |  |  |  |  |  |  | (2,883) | (1,836) | (137)
Noncontrolling interests’ share of consolidated joint venture operating expenses |  |  |  |  |  |  |  |  |  |  | 87 | 87 | 72
Adjustments to NOI |  |  |  |  |  |  |  |  |  |  | (62,754) | (46,589) | (20,133)
Adjusted NOI |  |  |  |  |  |  |  |  |  |  | 552,533 | 503,927 | 411,302
Plus: Adjustments to NOI |  |  |  |  |  |  |  |  |  |  | 62,754 | 46,589 | 20,133
Interest income |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
Interest expense |  |  |  |  |  |  |  |  |  |  | 0 | (232) | (234)
Depreciation and amortization |  |  |  |  |  |  |  |  |  |  | (302,649) | (303,196) | (217,921)
General and administrative |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
Transaction costs |  |  |  |  |  |  |  |  |  |  | (387) | (24) | (236)
Impairments and loan loss reserves, net |  |  |  |  |  |  |  |  |  |  | 0 | 0 | (14,671)
Gain (loss) on sales of real estate, net |  |  |  |  |  |  |  |  |  |  | 3,744 | 0 | 0
Gain (loss) on debt extinguishments |  |  |  |  |  |  |  |  |  |  |  | 0 | 0
Other income (expense), net |  |  |  |  |  |  |  |  |  |  | 311,939 | 55 | 0
Less: Government grant income |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
Less: Healthpeak’s share of unconsolidated joint venture NOI |  |  |  |  |  |  |  |  |  |  | (7,038) | (3,921) | (311)
Plus: Noncontrolling interests’ share of consolidated joint venture NOI |  |  |  |  |  |  |  |  |  |  | 181 | 205 | 167
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures |  |  |  |  |  |  |  |  |  |  | 621,077 | 243,403 | 198,229
Income tax benefit (expense) |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
Equity income (loss) from unconsolidated joint ventures |  |  |  |  |  |  |  |  |  |  | (972) | 1,118 | (40)
Income (loss) from continuing operations |  |  |  |  |  |  |  |  |  |  | 620,105 | 244,521 | 198,189
Income (loss) from discontinued operations |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
Net income (loss) |  |  |  |  |  |  |  |  |  |  | 620,105 | 244,521 | 198,189
Medical Office |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information, Revenue for Reportable Segment [Abstract] |  |  |  |  |  |  |  |  |  |  |  |  |
Gain (loss) on sales of real estate, net | $ 1,000 |  |  |  | $ 10,000 |  |  |  |  |  |  |  |
Medical Office | Operating Segment |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information, Revenue for Reportable Segment [Abstract] |  |  |  |  |  |  |  |  |  |  |  |  |
Total revenues |  |  |  |  |  |  |  |  |  |  | 725,370 | 671,242 | 622,398
Government grant income |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
Less: Interest income |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
Healthpeak’s share of unconsolidated joint venture total revenues |  |  |  |  |  |  |  |  |  |  | 2,999 | 2,882 | 2,772
Healthpeak’s share of unconsolidated joint venture government grant income |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
Noncontrolling interests’ share of consolidated joint venture total revenues |  |  |  |  |  |  |  |  |  |  | (35,717) | (35,363) | (34,597)
Operating expenses |  |  |  |  |  |  |  |  |  |  | (253,309) | (223,383) | (204,008)
Healthpeak’s share of unconsolidated joint venture operating expenses |  |  |  |  |  |  |  |  |  |  | (1,178) | (1,174) | (1,129)
Noncontrolling interests’ share of consolidated joint venture operating expenses |  |  |  |  |  |  |  |  |  |  | 10,317 | 10,071 | 10,282
Adjustments to NOI |  |  |  |  |  |  |  |  |  |  | (15,513) | (11,118) | (5,544)
Adjusted NOI |  |  |  |  |  |  |  |  |  |  | 432,969 | 413,157 | 390,174
Plus: Adjustments to NOI |  |  |  |  |  |  |  |  |  |  | 15,513 | 11,118 | 5,544
Interest income |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
Interest expense |  |  |  |  |  |  |  |  |  |  | (6,900) | (2,837) | (400)
Depreciation and amortization |  |  |  |  |  |  |  |  |  |  | (279,546) | (255,746) | (222,165)
General and administrative |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
Transaction costs |  |  |  |  |  |  |  |  |  |  | (1,255) | (323) | 0
Impairments and loan loss reserves, net |  |  |  |  |  |  |  |  |  |  | 0 | (21,577) | (10,208)
Gain (loss) on sales of real estate, net |  |  |  |  |  |  |  |  |  |  | 10,659 | 190,590 | 90,390
Gain (loss) on debt extinguishments |  |  |  |  |  |  |  |  |  |  |  | 0 | 0
Other income (expense), net |  |  |  |  |  |  |  |  |  |  | 12,709 | (2,725) | 0
Less: Government grant income |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
Less: Healthpeak’s share of unconsolidated joint venture NOI |  |  |  |  |  |  |  |  |  |  | (1,821) | (1,708) | (1,643)
Plus: Noncontrolling interests’ share of consolidated joint venture NOI |  |  |  |  |  |  |  |  |  |  | 25,400 | 25,292 | 24,315
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures |  |  |  |  |  |  |  |  |  |  | 207,728 | 355,241 | 276,007
Income tax benefit (expense) |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
Equity income (loss) from unconsolidated joint ventures |  |  |  |  |  |  |  |  |  |  | 852 | 794 | 798
Income (loss) from continuing operations |  |  |  |  |  |  |  |  |  |  | 208,580 | 356,035 | 276,805
Income (loss) from discontinued operations |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
Net income (loss) |  |  |  |  |  |  |  |  |  |  | 208,580 | 356,035 | 276,805
CCRC | Operating Segment |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information, Revenue for Reportable Segment [Abstract] |  |  |  |  |  |  |  |  |  |  |  |  |
Total revenues |  |  |  |  |  |  |  |  |  |  | 494,935 | 471,325 | 436,494
Government grant income |  |  |  |  |  |  |  |  |  |  | 6,765 | 1,412 | 16,198
Less: Interest income |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
Healthpeak’s share of unconsolidated joint venture total revenues |  |  |  |  |  |  |  |  |  |  | 0 | 6,903 | 35,392
Healthpeak’s share of unconsolidated joint venture government grant income |  |  |  |  |  |  |  |  |  |  | 380 | 200 | 920
Noncontrolling interests’ share of consolidated joint venture total revenues |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
Operating expenses |  |  |  |  |  |  |  |  |  |  | (400,539) | (380,865) | (440,528)
Healthpeak’s share of unconsolidated joint venture operating expenses |  |  |  |  |  |  |  |  |  |  | 0 | (6,639) | (32,125)
Noncontrolling interests’ share of consolidated joint venture operating expenses |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
Adjustments to NOI |  |  |  |  |  |  |  |  |  |  | 2,300 | 3,241 | 97,072
Adjusted NOI |  |  |  |  |  |  |  |  |  |  | 103,841 | 95,577 | 113,423
Plus: Adjustments to NOI |  |  |  |  |  |  |  |  |  |  | (2,300) | (3,241) | (97,072)
Interest income |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
Interest expense |  |  |  |  |  |  |  |  |  |  | (7,509) | (7,701) | (7,227)
Depreciation and amortization |  |  |  |  |  |  |  |  |  |  | (128,374) | (125,344) | (113,851)
General and administrative |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
Transaction costs |  |  |  |  |  |  |  |  |  |  | (725) | (1,445) | (17,994)
Impairments and loan loss reserves, net |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
Gain (loss) on sales of real estate, net |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
Gain (loss) on debt extinguishments |  |  |  |  |  |  |  |  |  |  |  | 0 | 0
Other income (expense), net |  |  |  |  |  |  |  |  |  |  | (1,380) | 2,141 | 187,844
Less: Government grant income |  |  |  |  |  |  |  |  |  |  | (6,765) | (1,412) | (16,198)
Less: Healthpeak’s share of unconsolidated joint venture NOI |  |  |  |  |  |  |  |  |  |  | (380) | (464) | (4,187)
Plus: Noncontrolling interests’ share of consolidated joint venture NOI |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures |  |  |  |  |  |  |  |  |  |  | (43,592) | (41,889) | 44,738
Income tax benefit (expense) |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
Equity income (loss) from unconsolidated joint ventures |  |  |  |  |  |  |  |  |  |  | 539 | 1,484 | (1,547)
Income (loss) from continuing operations |  |  |  |  |  |  |  |  |  |  | (43,053) | (40,405) | 43,191
Income (loss) from discontinued operations |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
Net income (loss) |  |  |  |  |  |  |  |  |  |  | (43,053) | (40,405) | 43,191
Other Non-Reporting Segment | Operating Segment |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information, Revenue for Reportable Segment [Abstract] |  |  |  |  |  |  |  |  |  |  |  |  |
Total revenues |  |  |  |  |  |  |  |  |  |  | 23,300 | 37,773 | 16,687
Government grant income |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
Less: Interest income |  |  |  |  |  |  |  |  |  |  | (23,300) | (37,773) | (16,553)
Healthpeak’s share of unconsolidated joint venture total revenues |  |  |  |  |  |  |  |  |  |  | 73,885 | 67,835 | 74,023
Healthpeak’s share of unconsolidated joint venture government grant income |  |  |  |  |  |  |  |  |  |  | 498 | 1,549 | 359
Noncontrolling interests’ share of consolidated joint venture total revenues |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
Operating expenses |  |  |  |  |  |  |  |  |  |  | 0 | 13 | 0
Healthpeak’s share of unconsolidated joint venture operating expenses |  |  |  |  |  |  |  |  |  |  | (57,632) | (51,866) | (53,779)
Noncontrolling interests’ share of consolidated joint venture operating expenses |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
Adjustments to NOI |  |  |  |  |  |  |  |  |  |  | 169 | (47) | 433
Adjusted NOI |  |  |  |  |  |  |  |  |  |  | 16,920 | 17,484 | 21,170
Plus: Adjustments to NOI |  |  |  |  |  |  |  |  |  |  | (169) | 47 | (433)
Interest income |  |  |  |  |  |  |  |  |  |  | 23,300 | 37,773 | 16,553
Interest expense |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
Depreciation and amortization |  |  |  |  |  |  |  |  |  |  | 0 | 0 | (12)
General and administrative |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
Transaction costs |  |  |  |  |  |  |  |  |  |  | 0 | (49) | (112)
Impairments and loan loss reserves, net |  |  |  |  |  |  |  |  |  |  | (7,004) | (1,583) | (18,030)
Gain (loss) on sales of real estate, net |  |  |  |  |  |  |  |  |  |  | (5,325) | 0 | (40)
Gain (loss) on debt extinguishments |  |  |  |  |  |  |  |  |  |  |  | 0 | 0
Other income (expense), net |  |  |  |  |  |  |  |  |  |  | (13) | 486 | 41,707
Less: Government grant income |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
Less: Healthpeak’s share of unconsolidated joint venture NOI |  |  |  |  |  |  |  |  |  |  | (16,751) | (17,518) | (20,603)
Plus: Noncontrolling interests’ share of consolidated joint venture NOI |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures |  |  |  |  |  |  |  |  |  |  | 10,958 | 36,640 | 40,200
Income tax benefit (expense) |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
Equity income (loss) from unconsolidated joint ventures |  |  |  |  |  |  |  |  |  |  | 1,566 | 2,704 | (65,810)
Income (loss) from continuing operations |  |  |  |  |  |  |  |  |  |  | 12,524 | 39,344 | (25,610)
Income (loss) from discontinued operations |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0
Net income (loss) |  |  |  |  |  |  |  |  |  |  | $ 12,524 | $ 39,344 | $ (25,610)

X
- Definition Adjusted NOI is a non-GAAP supplemental financial measure used to evaluate the operating performance of real estate. Adjusted NOI is calculated as NOI after eliminating the effects of straight-line rents, DFL non-cash interest, amortization of market lease intangibles and lease termination fees (?non cash adjustments?). Adjusted NOI is oftentimes referred to as ?cash NOI.? The Company uses adjusted NOI to make decisions about resource allocations, and to assess and compare property level performance. The Company believes that net income (loss) is the most directly comparable U.S. GAAP measure to adjusted NOI. Adjusted NOI should not be viewed as an alternative measure of operating performance to net income (loss) as defined by GAAP since it does not reflect various excluded items. Further, the Company?s definition of Adjusted NOI may not be comparable to the definition used by other REITs or real estate companies, as they may use different methodologies for calculating Adjusted NOI. + References No definition available. + Details
Name: | peak_AdjustedNetOperatingIncomeFromContinuingOperations
Namespace Prefix: | peak_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance On Deferred Assets No Longer Realized, Amount + References No definition available. + Details
Name: | peak_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowanceOnDeferredAssetsNoLongerRealizedAmount
Namespace Prefix: | peak_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Effective Income Tax Rate Reconciliation, Coronavirus Aid, Relief, And Economic Security (CARES) Act, Amount + References No definition available. + Details
Name: | peak_EffectiveIncomeTaxRateReconciliationCoronavirusAidReliefAndEconomicSecurityCARESActAmount
Namespace Prefix: | peak_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Government Grant Income From CARES Act + References No definition available. + Details
Name: | peak_GovernmentGrantIncomeFromCARESAct
Namespace Prefix: | peak_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Impairments And Allowance For Credit Loss Reserves (Recoveries), Net + References No definition available. + Details
Name: | peak_ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet
Namespace Prefix: | peak_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Interest Income Excluded From Adjusted Government Grant Income From Continuing Operations + References No definition available. + Details
Name: | peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations
Namespace Prefix: | peak_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Interest Income Excluded From Adjusted Net Operating Income From Continuing Operations + References No definition available. + Details
Name: | peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations
Namespace Prefix: | peak_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Net Income Loss Joint Venture Partners Attributable To Parent + References No definition available. + Details
Name: | peak_NetIncomeLossJointVenturePartnersAttributableToParent
Namespace Prefix: | peak_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Represents straight-line rents, DFL accretion, amortization of market lease intangibles and lease termination fees. + References No definition available. + Details
Name: | peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations
Namespace Prefix: | peak_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Operating Expenses From Joint Venture Attributable To Noncontrolling Interest + References No definition available. + Details
Name: | peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest
Namespace Prefix: | peak_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Operating Expenses From Joint Venture Attributable To Parent Net + References No definition available. + Details
Name: | peak_OperatingExpensesFromJointVentureAttributableToParentNet
Namespace Prefix: | peak_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Real Estate Revenues From Joint Venture Attributable To Noncontrolling Interest + References No definition available. + Details
Name: | peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest
Namespace Prefix: | peak_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Real Estate Revenues From Joint Venture Attributable To Parent + References No definition available. + Details
Name: | peak_RealEstateRevenuesFromJointVentureAttributableToParent
Namespace Prefix: | peak_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Real Estate Revenues From Joint Venture Government Grant Income + References No definition available. + Details
Name: | peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome
Namespace Prefix: | peak_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Represents the addback of straight-line rents, DFL accretion, amortization of market lease intangibles and lease termination fees from segment portfolio income to consolidated net income. + References No definition available. + Details
Name: | peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments
Namespace Prefix: | peak_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 25 -Paragraph 23 -URI https://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460 + Details
Name: | us-gaap_BusinessCombinationAcquisitionRelatedCosts
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585 + Details
Name: | us-gaap_DepreciationAndAmortization
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 50 -Section 40 -Paragraph 4 -URI https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 50 -Section 40 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585 + Details
Name: | us-gaap_GainsLossesOnExtinguishmentOfDebt
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The net gain (loss) resulting from sales and other disposals of real estate owned for investment purposes. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(b)(9)(a)) -URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 360 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=123605587&loc=d3e23528-158515 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(b)(7)(c)) -URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227 Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 220 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04(14)(d)) -URI https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 360 -Section 45 -Paragraph 4 -URI https://asc.fasb.org/extlink&oid=123605564&loc=d3e23439-158514 Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 220 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(3)(a)) -URI https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 360 -Section 45 -Paragraph 3 -URI https://asc.fasb.org/extlink&oid=123605564&loc=d3e23415-158514 + Details
Name: | us-gaap_GainsLossesOnSalesOfInvestmentRealEstate
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.4) -URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227 + Details
Name: | us-gaap_GeneralAndAdministrativeExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (f) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 + Details
Name: | us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (f) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756 Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 19 -URI https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 40 -Section 65 -Paragraph 1 -Subparagraph (f) -URI https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756 Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756 Reference 18: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599 Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b)(2) -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794 Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 28 -Subparagraph (f) -URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612 + Details
Name: | us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 220 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(12)) -URI https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 7 -URI https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 45 -Paragraph 3B -URI https://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 5C -Subparagraph (b)(2) -URI https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 45 -Paragraph 3 -URI https://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759 Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760 Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 45 -Paragraph 3A -URI https://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759 Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 45 -Paragraph 4 -URI https://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 270 -Section 45 -Paragraph 3 -URI https://asc.fasb.org/extlink&oid=109227538&loc=d3e44648-109337 + Details
Name: | us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of income (loss) for proportionate share of equity method investee's income (loss). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(12)) -URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 220 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(10)) -URI https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 220 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04(13)(f)) -URI https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (g) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 45 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570 + Details
Name: | us-gaap_IncomeLossFromEquityMethodInvestments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 6.I.7) -URI https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 10 -URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (h) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(h)) -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 9 -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 20 -Section 45 -Paragraph 2 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 220 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(9)) -URI https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 8 -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794 + Details
Name: | us-gaap_IncomeTaxExpenseBenefit
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible restructuring charges. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 12 -URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319 + Details
Name: | us-gaap_IncomeTaxReconciliationNondeductibleExpenseRestructuringCharges
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of the cost of borrowed funds accounted for as interest expense. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 835 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 835 -SubTopic 30 -Section 45 -Paragraph 3 -URI https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (210.5-03(11)) -URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 220 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04.9) -URI https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260 + Details
Name: | us-gaap_InterestExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of operating interest income, including, but not limited to, amortization and accretion of premiums and discounts on securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1(e)) -URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227 + Details
Name: | us-gaap_InterestIncomeOperating
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount after tax of income (loss) attributable to nonredeemable noncontrolling shareholder, unit holder, partner, or other equity holder of a joint venture. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.19) -URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227 + Details
Name: | us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. + References No definition available. + Details
Name: | us-gaap_OperatingExpenses
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of income (expense) related to nonoperating activities, classified as other. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.9) -URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227 + Details
Name: | us-gaap_OtherNonoperatingIncomeExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 1A -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 1A -Subparagraph (a)(1) -URI https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 9 -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 40 -Section 65 -Paragraph 1 -Subparagraph (f) -URI https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756 Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 50 -Paragraph 6 -URI https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 19 -URI https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (f) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 7 -URI https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760 Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b)(2) -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794 Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 28 -Subparagraph (f) -URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612 Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 235 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-05(b)(2)) -URI https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884 Reference 23: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599 Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 1B -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580 Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756 Reference 26: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756 Reference 27: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756 Reference 28: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756 Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756 Reference 30: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 1A -Subparagraph (c)(1) -URI https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684 Reference 31: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 55 -Paragraph 4J -URI https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686 Reference 32: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 55 -Paragraph 4K -URI https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686 Reference 33: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 8 -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794 + Details
Name: | us-gaap_ProfitLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 28 -Subparagraph (f) -URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690 Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 235 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-05(b)(2)) -URI https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884 Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756 Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756 Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(1)) -URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227 + Details
Name: | us-gaap_Revenues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingInformationRevenueAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=peak_LifeScienceMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=peak_CCRCSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=peak_OtherNonReportingSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |